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Citrus fruits have been used as an edible fruit and a traditional medicine since ancient times. In particular, the peels of immature
citrus fruits are used widely in traditional herbal medicine in Korea, as they are believed to contain bioactive components
exerting anti-inﬂammatory activity. This study examined whether the crude methanol extract of Citrus aurantium L. (CME)
has a suppressive eﬀect on inducible enzymes and proinﬂammatory cytokines by inhibiting the NF-κB pathway in LPS-stimulated
macrophage RAW 264.7 cells. The cells were pretreated with the indicated concentrations of CME (5, 10, 20, and 50μg/mL) and
then treated with LPS (1μg/mL). The results showed that CME (10, 20, and 50μg/mL) inhibited the LPS- (1μg/mL) induced
mRNA and protein expression of iNOS in macrophage Raw 264.7 cells. In addition, the expression of COX-2 was inhibited
at the mRNA and protein levels by CME in a dose-dependent manner. The mRNA expression of proinﬂammatory cytokines,
such as TNF-α and IL-6, were markedly reduced by CME (10, 20, and 50μg/mL). Moreover, CME clearly suppressed the
nuclear translocation of the NF-κB p65 subunits, which was correlated with its inhibitory eﬀect on I-κB phosphorylation. These
results suggest that CME has anti-inﬂammatory properties by modulating the expression of COX-2, iNOS, and proinﬂammatory
cytokines, such as TNF-α and IL-6, in macrophage RAW 264.7 cells via the NF-κBp a t h w a y .
1.Introduction
Citrus aurantium L. (bitter orange) is a ﬂowering plant that
belongs to the Rutaceae family of the order Sapindales,a n d
is distributed widely in tropical and subtropical southeast
regions of the world. The dried, entire immature peels
of citrus fruit are used as a traditional herbal medicine
to treat indigestion and respiratory symptoms, such as
bronchial and asthmatic conditions [1, 2]. Citrus fruit
including C. aurantium L. is composed of several compo-
nents, such as limonoid, polyphenols, and ﬂavonoids [3].
The major ﬂavonoids isolated from Citrus aurantium L. are
hesperidin, naringenin, and nobiletin [4]. These ﬂavonoids
have the ability to regulate the inﬂammatory response and
carcinogenesis at many key regulatory points through a
variety of mechanisms [5]. Nobiletin isolated from Citrus
spp. has an inhibitory eﬀect on phorbol ester-induced skin
inﬂammation [6, 7]. In addition, it was reported that2 Evidence-Based Complementary and Alternative Medicine
hesperidin can inhibit the expression of lipopolysaccharine-
(LPS-)inducedcyclooxygenase(COX-2)andinduciblenitric
oxide (iNOS) in macrophage RAW 264.7 cells [8]. Therefore,
thisstudyexaminedtheanti-inﬂammatoryeﬀectofthedried
peel of Citrus aurantium L.
Inﬂammation initiated by the invasion of pathogens or
cell injury is a normal physiological and immune response.
Thenormalinﬂammatoryresponseinvolvestheactivationof
several diﬀerent cellular components, such as macrophages,
neutrophils, and lymphocytes. In particular, macrophages
play an important role in modulating inﬂammation and
the immune response to maintain a defensive reaction
[9, 10]. During the inﬂammatory response, activated
macrophages secrete large amounts of proinﬂammatory
mediators, such as nitric oxide (NO) and prostaglandinE2
(PGE2), via the inducible isoforms of NO synthase (iNOS)
and cyclooxygenase-2 (COX-2), respectively, as well as
proinﬂammatory cytokines, such as TNF-α, IL-6, and IL-1β
[11, 12].
Most NO is synthesized through the oxidative deami-
nation of L-arginine by a family of nitric oxide synthase
(NOS) in mammalian cells [13]. These NOSs are found in
three isoforms, neuronal NOS (nNOS), endothelial NOS
(eNOS), and inducible NOS (iNOS). In particular, during
the inﬂammatory response, iNOS is expressed in response
to endotoxin, such as LPS and various proinﬂammatory
cytokines including INF-γ and TNF-α [14]. In addition,
NO produced by iNOS is regarded as a critical mediator of
carcinogenesis and high levels of NO cause inﬂammatory
diseases, such as atherosclerosis, bowel disease, rheumatoid
arthritis, and septic shock [15–18].
Similar to iNOS, cyclooxygenase (COX) is a key enzyme
catalyzing the formation of prostaglandin from arachidonic
acid during the inﬂammatory reaction [19]. There are
two types of cyclooxygenase, COX-1 and COX-2. COX-1
is expressed constitutively in most cells and believed to
be involved in homeostatic prostanoid biosynthesis. In
contrast, COX-2 is not expressed in most normal tissues
but is increased rapidly by oncogenes, growth factors, and
cytokines [20] .C O X - 2i si n v o l v e di nm a n yb i o l o g i c a lp r o -
cesses, including inﬂammation, tumorigenesis, and carcino-
genesis [21]. Brieﬂy, the overexpression of proinﬂammatory
mediators, such as iNOS, COX-2, and various cytokines,
is involved in the pathogenesis of many disease processes.
Therefore, the targeted inhibition of iNOS and COX-2
is a promising approach to inhibiting inﬂammation and
carcinogenesis, as well as preventing cancer.
Nucleartranscriptionfactorkappa-B(NF-κB)isacritical
key transcription factor that expresses the genes involved
in inﬂammation. NF-κBi sc o m p o s e do far a n g eo fh o m o
or heterodimeric combinations of NF-κB/Rel proteins, such
as Rel (cRel), RelA (p65), RelB, NF-κB1 (p50), and NF-
κB2 (p52) in mammals. The main inducible form is a
heterodimeric consisting of the p50/p65 subunit. NF-κBi s
present in the cytoplasm as an inactive complex associated
with an inhibitory protein called IκB. Various external or
internal stimuli cause the dissociation of the NF-κB/IκB
complex through the phosphorylation and degradation of
IκB by cytoplasmic IκB kinase (IKK). After activation, the
NF-κB heterodimer (p65/p50) is translocated rapidly from
the cytoplasm to the nucleus (Figure 1). In the nucleus,
p65/p50 of the NF-κB subunit binds to a speciﬁc DNA motif
and modulates the transcription of target genes including
proinﬂammatory mediators, such as iNOS, COX-2, various
cytokines, chemokines, and adhesion molecules [22–24].
Previous studies suggested that the activation of NF-κB
triggers the transcription of iNOS, COX-2, and various
proinﬂammatory cytokines, such as IL-6, IL-1, and TNF-α
[25].
Therefore, the objective of this study is to elucidate
the anti-inﬂammatory eﬀects of crude methanol extract of
Citrus aurantium L. on the expression of iNOS, COX-2,
IL-6, and TNF-α via blocking of NF-κB signal pathway
in LPS-stimulated macrophage RAW 264.7 cells. Thus, we
investigated the following: (1) the inhibitory eﬀect of CME
on the LPS-induced iNOS and COX-2 at the mRNA and
protein levels; and (2) the inhibitory eﬀect of CME on the
LPS-inducedproinﬂammatorycytokines,suchasTNF-αand
IL-6.
2. Methods
2.1. Chemicals. The following reagents were acquired
commercially: RPMI 1640 from HyClone (Logan, Utah,
USA); Fetal bovine serum (FBS) and antibiotics (strepto-
mycin/penicillin) from Gibco (BRL Life technologies, Grand
Island, NY,); Lipopolysaccharide (Escherichia coli O111:B4)
and methyl thiazolyl tetrazolium (MTT) from Sigma (St
Louis, MO 63103, USA).
2.2. Antibodies. Antibodies for iNOS, COX-2, and NF-κB
p65 were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA,). β-actin antibody was purchased from Chemicon
International (Temecula, CA,) and phospho-IκB antibody
was purchased from Cell Signaling (Beverly, MA, USA).
2.3. Cell Culture and Treatment. The murine macrophage
RAW 264.7 cell line (KCKB 40071) was purchased from
the Korean Cell Line Bank (KCLB, Seoul, Korea). Mouse
macrophage cell line RAW 264.7 was cultured in RPMI
1640 medium containing 10% fetal bovine serum, 100
U/ml penicillin, and 100μg/μLs t r e p t o m y c i na t3 7 ◦Ci na n
atmosphere containing 5% CO2.T h ec e l l sc u l t u r e di n6
well-plateswerepretreatedwiththeindicatedconcentrations
of CME for 2 hours in the presence or absence of LPS
(1μg/mL).
2.4. Preparation of Herbal Extracts. Citrus aurantium L. was
purchased from ABRB (Animal Bio-Resources Bank). The
extract of C. aurantium L. was prepared using a modiﬁed
method reported by Jung et al. [3]. Brieﬂy, the powdered
peel of C. aurantium L. ( 2 0 g )w a se x t r a c t e di n2 0 0 m L
of absolute methanol at room temperature for 48 hours.
The methanolic extracts were ﬁltered through ﬁlter paper,
evaporated in vacuo, and lyophilized to give a powdered
extract. The yield of the citrus methanol extract was 10%Evidence-Based Complementary and Alternative Medicine 3
(w/v). The concentrated CME was dissolved in PBS (pH 7.4)
a n ds t o r e da t−20◦C until needed.
2.5.MTTAssay. Thecellviabilitywasmeasuredusinga3-(4,
5-dimethyethiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) assay. The cells were seeded in a 6-well plate and
incubated for 24 hours. The macrophage cells were treated
with various concentrations of CME and incubated for 18
hours. 200μL of a MTT solution (5mg/mL in a PBS) was
addedtothewellsandincubatedforthreehours.Aftermedia
suction, 500μL of dimethyl sulfoxide (DMSO) was added to
each well to dissolve the crystalline deposits on the cells. The
optical density of the cells at 540nm was measured using an
ELISA plate reader.
2.6. Western Blot. The cells were cultured in 6-well plates
and incubated with CME (various concentrations) in the
presence or absence of LPS (1μg/mL) for 18 hours. After
washing with ice-cold PBS, the cells were lysed in a buﬀer
[50mM Tris-Hcl (pH 8.0), 150mM NaCl, 0.5% sodium
deoxycholate, 0.1% SDS, and 1% NP-40] containing the
protease inhibitor cocktail, 0.5M EDTA, and phosphatase
inhibitor at a ﬁnal concentration of 1X. The cell lysates
were centrifuged at 13,000rpm for 30 minutes to remove
the debris. The protein concentration was determined
using Bradford assay (Bio-rad, Hercules, CA, USA). The
entire cell lysates were separated by 10% SDS-PAGE and
transferred to a polyvinylidene ﬂuoride (PVDF) membrane
(Immunobilon-P, 0.45mm; Millipore, USA) using the TE
77 Semi-Dry Transfer Unit (CE Healthcare Life Sciences).
The membranes were blocked with 5% nonfat skim milk
in Tris buﬀered saline containing 0.5% Tween-20 (TBS, pH
7.4) at room temperature for 30 minutes, and incubated
overnight at 4◦C with the antibodies to iNOS, COX-2, β-
actin, p-IκB, and NF-κB p65. The membranes were washed
four times with TBS-T for 10 minutes each and incubated
witha1:2000dilutionofhorseradishperoxidase-conjugated
secondary antibody for 1 hour. The membranes were then
rewashedﬁvetimeswithTBS-T.Theproteinswerevisualized
using an enhanced chemiluminescence kit (ECL), Western
Blotting Detection Reagents (GE Healthcare Life Sciences),
and exposed to X-ray ﬁlm (Fuji, Tokyo, Japan). Then each
band was quantitatively determined using Image J, and the
density ratio represented the relative intensity of each band
against those of β-actin as a control in each experiment.
2.7. Reverse-Transcription Polymerase Chain Reaction (RT-
PCR). The total RNA was isolated using a TRIzol reagent
(GeneALL Biotechnology CO., LTD, KOREA), according to
the manufacturer‘s instructions. The total RNA (1μg) was
reverse-transcribed into cDNA using commercially available
cDNAsynthesiskits(iScriptcDNASynthesisKit;BIO-RAD).
The tubes were incubated at 25◦C for 5 minutes and then
at 42◦C for 30 minutes followed by heating at 85◦Cf o r5
minutes. The sample was then stored at −70◦C until further
analysis. The PCR primers used with mouse macrophage
RAW 264.7 cell cDNA are listed in Table 1.T h eP C Rp r i m e r s
used to amplify the mouse COX-2, NOS2, TNF-α,I L - 6 ,a n d
GAPDH cDNA were purchased from Bioneer Corporation
Inc.Afterinitialheatdenaturationat95◦Cfor4minutes.,the
P C Rc y c l e sw e r er e p e a t e d3 0 ∼35 times under the following
conditions: denaturation at 95◦C for 30 seconds, annealing
at 52∼55◦C for 1 minute, and extension at 72◦Cf o r
1 minute. The ampliﬁed PCR products were stored at
−20◦C until analysis. The PCR products were analyzed on
ethidium bromide-stained 1.5% agarose gels. The amount of
mRNAwasevaluatedbydensitometry.Thesignalintensityof
the speciﬁc mRNAs were normalized by a comparison with
that of GAPDH and calculated as the relative amounts.
2.8. Statistical Analysis. The data is presented as the mean
± SD of the results of at least three experiments. One-
way analysis of variance (ANOVA) was used for multiple
comparison. A P-value <. 05 was considered signiﬁcant.
3. Results
3.1. Cell Cytotoxicity and Morphology of Macrophage RAW
264.7 Cells. The cytotoxicity of CME was examined by a
MTT assay in the presence or absence of LPS (1μg/mL) to
determine the eﬀective concentration for treatment. Figure 2
shows the cell viability at various CME concentrations (5,
10, 20, 50, and 100μg/mL) and cotreated LPS (1μg/mL) for
18 hours. The results showed that LPS (1μg/mL) and CME
had no cytotoxicity at any of the concentrations examined.
Figure 3 presents the cell morphology of the macrophage
RAW 264.7 cells under CME treatment in the presence or
absence of LPS (1μg/mL). The cells were monitored under
optical microscopy (400×) for 18 hours; see Figure 3.I n
the LPS-unstimulated cells, the cell morphology generally
showed a round form the in whereas LPS-activated RAW
264.7 cells had changed to an irregular form with accelerated
spreading and forming pseudopodia. The cotreatment of
LPS with CME reduced the level of cell spreading and
pseudopodia formation by suppressing cell diﬀerentiation.
3.2. CME Decreases LPS-Induced mRNA Expression of Proin-
ﬂammatory Cytokines in RAW 264.7 Cells. To examine the
eﬀect of CME on LPS-induced IL-6 and TNF-α gene
expression, the RAW 264.7 cells were pretreated with various
doses (5, 10, 20, and 50μg/mL) of CME for 1 hour followed
by a LPS (1μg/mL) treatment for 6 hours. The level of
IL-6 and TNF-α gene expression in the RAW 264.7 cells
was increased markedly by the LPS treatment (1μg/mL).
The level of LPS-induced IL-6 and TNF-α gene expression
decreased signiﬁcantly on pretreatment with CME in the
dose-dependent manner (Figure 4). This suggests that CME
inhibited the mRNA expression of IL-6 and TNF-α in LPS-
stimulated RAW 264.7 cells at the transcription levels.
3.3. CME Decreases LPS-Induced mRNA Expression of COX-
2 and iNOS in RAW 264.7 Cells. The expression of iNOS
and COX-2 mRNA was examined by RT-PCR to determine
if CME has a suppressive eﬀect on the proinﬂammatory
mediators, such as iNOS and COX-2, in the LPS-stimulated
RAW 264.7 cells. As shown in Figure 5, upon LPS treatment4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Main molecular targets of CME that lead to inhibitory eﬀects on LPS-induced inﬂammation action. CME blocking NF-
κB signaling pathway via inhibition of (i) IκB phosphorylation, (ii) subunits (p65/p50) of NF-κB trnaslocation in nuclear, and (iii)
proinﬂammatory mediators (COX-2, iNOS, etc.) transcription. Blue arrows indicate the NF-κB signal pathway and target gene that DNA
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Figure 2: Eﬀect of CME on the cell viability via an MTT assay. The cells were incubated with CME in the (a) absence or (b) presence of LPS
for 18 hours. The results are reported as a percentage compared to the untreated controls. The data is reported as the mean ± SD of triplicate
experiments.
for 6 h, the mRNA expression of COX-2 increased consid-
erably in RAW 264.7 cells. However, the mRNA expression
of COX-2 induced in cells treated with LPS was decreased
signiﬁcantly by 20μg/mL and 50μg/mL CME compared to
cells treated with LPS alone. The mRNA expression of iNOS
was also found to increase in the stimulated LPS macrophage
RAW 264.7 cells. However, the LPS-induced iNOS mRNA
expression was decreased by 10μg/mL, 20μg/mL, and
50μg/mL CME (Figure 5). This suggests that CME may
inhibit the mRNA expression of iNOS and COX-2 at the
transcription level in LPS-stimulated RAW 264.7 cells.
3.4. CME Decreases LPS-Induced Protein Expression of iNOS
and COX-2 in RAW 264.7 Cells. The eﬀect of CME on
the expression of iNOS and COX-2 at the protein levels
was examined by western blot analysis. Figure 6 shows a
representativewesternblotofCOX-2andiNOSinthetreated
cells. After the LPS treatment for 18 hours, the levels of iNOS
and COX-2 protein expression was obviously increased, but
a cotreatment with LPS and CME (various concentrations)
signiﬁcantly attenuated the expression of the iNOS and
COX-2 proteins in a dose-dependent manner (Figure 6).
This suggests that the expression of the iNOS and COX-2Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Morphological change in macrophage RAW 264.7 cells. Morphology of macrophage RAW 264.7 cell visualized by optical
microscopy (×400). The cells were pretreated with CME before incubation with LPS for 18 hours. (a) Control, (b) LPS- (1μg/mL) treated
only, and (c) LPS-treated with CME (50μg/mL).6 Evidence-Based Complementary and Alternative Medicine
0
0.2
0.4
m
R
N
A
r
e
l
a
t
i
v
e
e
x
p
r
e
s
s
i
o
n
(
T
N
F
-
α
/
G
A
P
D
H
)
0.6
0.8
∗
∗∗
∗∗
∗∗
1
1.2
GAPDH
TNF-α
LPS (1μg/mL)
CME (μg/mL)
−
−
+
−
+
5
+
10
+
20
+
50
−−5
LPS (1μg/mL)
CME
(μg/mL)
10 20 50
(a)
0
0.2
0.4
m
R
N
A
r
e
l
a
t
i
v
e
e
x
p
r
e
s
s
i
o
n
(
I
L
-
6
/
G
A
P
D
H
)
0.6
0.8
∗
∗∗
∗∗
∗∗
1
1.4
1.2
GAPDH
IL-6
LPS (1μg/mL)
CME (μg/mL)
−
−
+
−
+
5
+
10
+
20
+
50
−−5
LPS (1μg/mL)
CME
(μg/mL)
10 20 50
(b)
Figure 4: Suppressive eﬀect of CME on the production of LPS-induced proinﬂammatory cytokines in RAW 264.7 cells. The RAW 264.7 cells
were pretreated with CME (5, 10, 20, and 50μg / m L )f o r1h o u r ,a n dt h e ns t i m u l a t e dw i t hL P S( 1μg/mL). After 6 hours, the total mRNA was
isolated, and the mRNA levels of (a) TNF-α and (b) IL-6 were examined by RT-PCR. ∗ indicates an increase in mRNA expression relative to
the control (P<. 05), ∗∗ indicates a decrease in mRNA expression relative to the LPS group (P<. 05).
Table 1: Primer design for RT-PCR.
Gene Direction Sequence (5 -3 )
TNF-α Sense AGCACAGAAAGCATGATCCG
Antisense GTTTGCTACGACGTGGGCTA
IL-6 Sense CGATGATGCACTTGCAGAAA
Antisense TGGAAATTGGGGTAGGAAGG
COX-2 Sense CCCAGAGCTCCTTTTCAACC
Antisense ATTTGGCACATTTCTTCCCC
iNOS Sense CTCCCCTCTCTCCCTTTCCT
Antisense TGGAAATTGGGGTAGGAAGG
GAPDH Sense AAGGGTCATCATCTCTGCCC
Antisense GTGATGGCATGGACTGTGGT
proteins in LPS-induced macrophage RAW 264.7 cells was
inhibited by CME.
3.5. CME Inhibits IκB Phosphorylation in Cytoplasm. In the
NF-κB signal pathway, the phosphorylation and degradation
of IκBi sac r u c i a ls t e pf o rN F - κBa c t i v a t i o ni na c t i v a t e d
macrophages. This study investigated whether CME inhibits
the LPS-induced phosphorylation of IκB and degradation of
IκB in RAW 264.7 macrophages by Western blot analysis.
As shown in Figure 7, the phosphorylated forms of IκB
were barely detectable in the unstimulated RAW 264.7 cells.
However, level of IκB phosphorylation was increased signif-
icantly after the LPS (1μg/mL) treatment for 30 minutes.
A pretreatment with CME moderately inhibited the LPS-
mediated IκB phosphorylation at all CME concentrations.
However, CME had no eﬀect on the level of IκBd e g r a d a t i o n
(data not shown).Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Suppressive eﬀects of CME on the LPS-induced mRNA expression of COX-2 and iNOS in RAW 264.7 cells. The RAW 264.7 cells
were pretreated with CME for 1 hour, and then incubated with LPS for 6 hours. The total mRNA was isolated, and the mRNA levels of (a)
COX-2 and (b) iNOS were performed by RT-PCR. ∗ indicates an increase in mRNA expression relative to the control (P<. 05), ∗∗ indicates
a decrease in mRNA expression relative to the LPS group (P<. 05).
3.6. CME Inhibits NF-κB Activation and Its Nuclear Translo-
cation. p65 of the NF-κB subunit is a major component
of NF-κB activated by LPS in macrophages, and the acti-
vation of NF-κB is initiated by IκBd e g r a d a t i o na f t e rI κB-
α phosphorylation. In this study, Western blot analysis was
used to determine if CME inhibited the activation of NF-κB
p65 and nuclear translocation of p65 as a result of the
inhibition of IκB-α phosphorylation. As shown in Figure 8,
p65 was less expressed in the cytosol fraction and strongly
expressed in the nuclear fraction after exposure to LPS.
However, p65 of the cytosol fraction and nuclear fraction
were increased and decreased by CME, respectively. Hence,
it is hypothesized that CME may block the LPS-induced
translocation of p65 from the cytosol to the nucleus by
inhibiting IκB phosphorylation.
4. Discussion
Herbal medicinal plants or extracts are used as an alternative
therapy. Citrus aurantium L. has been used as a tradi-
tional medicine to treat the inﬂammatory response. Many
studies have reported the pharmaceutical eﬀects of natural
herbal products, such as anti-inﬂammatory, anticancer,
and antioxidative eﬀects, and so forth [26–28]. Recent
reports suggest that natural herbs have an anti-inﬂammatory
eﬀect by regulating the activation of transcription factors
including NF-κB or activator protein-1 (AP-1). In partic-
ular, ﬂavonoids, such as epigallocatechin gallate (EGCG),
curcumin, and quercetin, have been reported to be potential
inhibitors via the NF-κBp a t h w a y[ 29, 30]. Flavonoids are
one of the most critical phytochemical compounds in many
plants, particularly in the genus Citrus [31]. Citrus-derived
ﬂavonoidssuchasnaringenin,nobiletin,andhesperidinhave
considerable biological activity, including anti-inﬂammatory
eﬀects [32]. Naringenin inhibited several cytokines induced
by LPS-stimulated macrophages [33]. Nobiletin suppressed
the production of PGE2 by downregulating the COX-2 gene
in human synovial ﬁbroblasts as well as decreasing the
expression of IL-1α,I L - 1 β,T N F - α, and IL-6 mRNAs in
mouse macrophages [34]. Zieli´ nska-Przyjemska and Igna-
towicz reported that citrus fruit ﬂavonoids have protective
eﬀects against oxidative stress related to inﬂammation [35].
The present study examined the suppressive eﬀect of
CME on the proinﬂammatory mediators in macrophage
RAW 264.7 cells. Therefore, an MTT assay was carried
out to examine the cytotoxicity of CME. CME did not
exhibit cytotoxicity at any of the concentrations examined.
The morphological change in macrophage RAW 264.7 cells
induced by the CME treatment in the presence or absence of
LPSwasalsoexamined.ThecellswereroundwithouttheLPS
treatment but became irregularly shaped showing increased
spreading and pseudopodia formation after LPS stimulation.8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Suppressive eﬀects of CME on the LPS-induced protein expression of COX-2 and iNOS in RAW 264.7 cells. RAW 264.7 cells
were pretreated with CME for 1 hour, and then incubated with LPS for 18 hours. The cells were lysed, and the lysates were examined by
immunoblotting for the protein of (a) COX-2 and (b) iNOS. ∗ indicates an increase in protein expression relative to the control (P<. 05),
∗∗ indicates a decrease in protein expression relative to the LPS group (P<. 05).
The cotreatment with 50μg/mL CME decreased the degree
of cell spreading and pseudopodia formation. Interestingly,
this amount of CME also decreased the levels of iNOS and
COX-2.
Inducible enzymes, such as iNOS and COX-2, are critical
factors in the inﬂammatory response, cell proliferation,
and skin tumor promotion [21, 36]. In the inﬂammatory
response, iNOS and COX-2 expression are involved in the
production of NO and prostaglandin, respectively. The over-
expression of iNOS and COX-2 is related to the pathogenesis
of a range of disease processes [11, 37]. Previous studies
reported that Zedoarondiol isolated from the rhizome of
Curcuma heyneana inhibits the LPS-induced expression
of iNOS and COX-2 with the concomitant reduction
of PGE2 and NO production in RAW 264.7 cells [38].
Y.-L. Lin and J.-K. Lin showed that (-)-epigallocatechin-3-
gallate (EGCG), one of the ﬂavonoids in green tea, decreased
the protein expression of iNOS by reducing the mRNA
levels of iNOS through the inhibition of NF-κB binding
[39]. Chrysin, a ﬂavonoid contained in propolis and honey,
inhibited LPS-induced expression of COX-2 in macrophages
by blocking the DNA-binding activity of C/EBP, which plays
a major role in inducing the expression of COX-2 [40].
Moreover, the methanol extract of Citrus reticulate decreased
the production of NO by suppressing the expression of iNOS
atthemRNAandproteinlevels[3].Therefore,theregulation
of iNOS and COX-2 is important in the inﬂammation
response. This study examined the eﬀect of CME on the
expression of iNOS and COX-2 at the protein and mRNA
levels. The results showed that CME dose dependently
suppressed the expression of COX-2 at both the protein
and mRNA levels. In addition, the expression of iNOS
protein and mRNA in LPS-stimulated macrophage RAW
264.7 cells was suppressed by various concentrations of CME
(10, 20, and 50μg/mL). This shows that CME inhibited the
expression of iNOS and COX-2 in LPS-stimulated RAW
264.7 cells at both the protein and mRNA levels.
Proinﬂammatory cytokines, such as IL-1β, IL-2, IL-6,
IL-10, and TNF-α, are important mediators in a range
of acute and chronic responses to inﬂammatory diseases
[29, 41, 42]. The production of TNF-α is essential for the
synergistic release of NO in IFN-γ and/or LPS-stimulated
macrophages. In addition, TNF-α is involved in many
physiological eﬀects, such as septic shock, inﬂammation,
cachexia, and cytotoxicity. IL-6 is believed to be an endoge-
nous pyrogen that causes fever by triggering metabolic
changes in the hypothalamic thermoregulatory center for the
duration of the inﬂammation response [11, 25]. This studyEvidence-Based Complementary and Alternative Medicine 9
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Figure 8: CME suppressed the LPS-induced activation and translocation of NF-κB in RAW 264.7 cells. The cells were pretreated with CME
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investigated the suppressive eﬀect of CME on LPS-induced
gene expression of IL-6 and TNF-α in macrophage RAW
264.7 cells. The results showed that the mRNA expression
of TNF-α and IL-6 in LPS-stimulated RAW 264.7 cells
was decreased by various concentrations of CME (10, 20,
and 50μg/mL). These results suggest that CME successfully
suppressed the expression of TNF-α a n dI L - 6i nL P S -
stimulated macrophages.
NF-κB is a major factor regulating the expression
of inﬂammation-induced enzymes and cytokines, such as
iNOS, COX-2, TNF-α, and IL-6, which include the NF-κB
binding sites in their promoters, and has attracted attention
as a new target for treating inﬂammatory diseases [43–
46]. Therefore, the suitable regulation of NF-κBm a yb e
beneﬁcialintreatingmanyinﬂammatorydisorders.Recently,
Jung et al. reported that the root of Panax notoginseng
(PN) inhibited the LPS-induced inﬂammatory mediators,
including iNOS and COX-2 by blocking IκBd e g r a d a t i o n
in the cytosol and the nuclear translocation of the NF-κB
p65 subunit [12]. Choi et al. showed that nobiletin isolated
from the fruit peel of Citrus sunki inhibits the expression
of the genes involved in inﬂammation by blocking the
DNA-binding activity of NF-κB. However, nobiletin did not
aﬀect the LPS-induced phosphorylation and degradation of
the IκB-α protein or the nuclear translocation of NF-κB
[47]. The present study examined whether CME inhibits
the LPS-induced degradation and phosphorylation of IκB
or the activation and translocation of NF-κB p65. These
results showed that CME inhibits signiﬁcantly the LPS-
induced activation and nuclear translocation of NF-κB
p65 at various concentrations (5, 10, 20, and 50μg/mL).
Moreover, in RAW 264.7 cells pretreated with CME, the
phosphorylation of IκB was inhibited in a dose-dependent
manner.However,therewerenosigniﬁcantdiﬀerencesinthe
level of IκB degradation (date not shown). These ﬁndings
suggest that CME suppresses NF-κB activation and nuclear
translocation in LPS-stimulated RAW 264.7 cells by blocking
the phosphorylation of IκB.
In summary, the anti-inﬂammatory activity of CME
was characterized by the suppression of iNOS, COX-2,
and various cytokines, such as TNF-α and IL-6, through
the NF-κB signal pathway. The results showed that CME
inhibits the LPS-induced expression of iNOS and COX-2
at the mRNA and protein levels as well as the expression
of TNF-α, IL-6 transcripts in macrophage RAW 264.7
cells. These suppressive eﬀects are mediated by inhibiting
the activation of NF-κB and phosphorylation of IκB. The
major transcriptional factors of the target gene, NF-κB, are
inactivated by CME. This is important because NF-κBp l a y s
a key role in modulating many genes related to the inﬂam-
matory response. These results suggest that crude methanol
extract of Citrus aurantium L. has anti-inﬂammatory prop-
erties, and may be eﬀective as a medicine for preventing
inﬂammation.
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